Cited by 42Treatment of Major DepressionAdvanced MRI Techniques and ApplicationsTryptophan and brain disorders

Proton magnetic resonance spectroscopy of N-acetyl aspartate in first depressive episode and chronic major depressive disorder: A systematic review and meta-analysis

Open access
Saccaro, Luigi F., Tassone, Matteo, Tozzi, Francesca, Rutigliano, Grazia·2024·Journal of Affective Disorders

Published version of a preprint

Abstract

Abstract N-acetyl aspartate (NAA) is a marker of neuronal integrity and metabolism. Deficiency in neuronal plasticity and hypometabolism are implicated in the pathophysiology of Major Depressive Disorder (MDD). To test if cerebral NAA concentrations decrease progressively over the MDD course, we conducted a meta-analysis of Proton Magnetic Resonance Spectroscopy ( 1 H-MRS) studies comparing NAA concentrations in chronic MDD (cMDD) and first episode of depression (FED) to healthy controls. We searched Scopus® and Web of Knowledge □ using search terms related to depression and NAA. Hedges’ g was used as effect size measure, together with heterogeneity analyses, test of moderators and publication bias and quality assessment. The protocol is registered in PROSPERO (CRD42020221050). Sixty-two studies were included and meta-analyzed using a random-effect model for each brain region. NAA concentrations were significantly reduced in cMDD compared to healthy controls within the frontal lobe (n=26, Hedges’ g= -0.330, 95% CI -0.598 to -0.062; p= 0.018), the occipital lobe (n = 4, Hedges’ g= -0.677, 95% CI -1.013 to -0.341; p = 0.007), the thalamus (n= 4, Hedges’ g= -0.673, 95% CI -1.108 to -0.238; p = 0.016) and the frontal (n = 6, Hedges’ g= -0.471, 95% CI -0.891 to -0.052; p= 0.034) and periventricular white matter (n= 3, Hedges’ g= -0.478, 95% CI -0.938 to -0.018; p= 0.047). We highlighted a gap of knowledge regarding NAA levels in FED. Sensitivity analyses indicated that antidepressant treatment may reverse NAA alterations in the frontal lobe. Our findings are in line with previous evidence showing alterations in the aforementioned brain areas in MDD. Future studies should assess NAA alterations in the early stages of the illness and their longitudinal progression, also considering our preliminary results on the modifying effect of antidepressant treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2024.03.150

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Saccaro, L. F., Tassone, M., Tozzi, F., & Rutigliano, G.
Affiliations
  • University of Geneva (CH)
  • University of Pisa (IT)
  • Scuola Normale Superiore (IT)
Corresponding author
Saccaro, Luigi F.
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2024-06
Volume
355
Pages
265-282
ISSN
0165-0327 (ISSN-L)
OpenAlex
W4393258906
Cited by
42
References
15
Citations by year
2026: 15 · 2025: 18 · 2024: 8 · 2023: 1
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • Journal of Affective Disorders (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Horizon 2020
  • Università di Pisa
  • Marine Stewardship Council
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
N-acetylaspartate, major depressive disorder, first-episode depression, chronic depression, 1H NMR, brain metabolites, neuronal integrity, frontal lobe, occipital lobe, thalamus, white matter, antidepressant treatment, field strength
MeSH terms
Aspartic Acid, Brain, Choline, Chronic Disease, Creatine, Depressive Disorder, Major, Major Depressive Disorder, Frontal Lobe, Humans, Magnetic Resonance Spectroscopy, Occipital Lobe, Thalamus, White Matter, Proton Magnetic Resonance Spectroscopy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review